Payment overview · 2025
General Payments
$52.64
2 reported records · 2 companies
Healthcare provider profile · identity verified
Kenny Smith, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · GADSDEN, AL · NPI 1295736460
Verified facts
What the public records show
CMS Open Payments records show Kenny Smith, M.D. received $52.64 in general payments during 2025 across 2 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 52.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Nuedexta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $27.83 | 52.9% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $24.81 | 47.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $52.64 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $52.64 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1349 | 164 |
| Atorvastatin Calcium | Atorvastatin Calcium | 867 | 128 |
| Levothyroxine Sodium | Levothyroxine Sodium | 722 | 74 |
| Furosemide | Furosemide | 705 | 80 |
| Eliquis | Apixaban | 667 | 46 |
| Amlodipine Besylate | Amlodipine Besylate | 605 | 112 |
| Carvedilol | Carvedilol | 585 | 102 |
| Pantoprazole Sodium | Pantoprazole Sodium | 537 | 99 |
| Potassium Chloride | Potassium Chloride | 519 | 82 |
| Gabapentin | Gabapentin | 474 | 72 |
| Losartan Potassium | Losartan Potassium | 436 | 81 |
| Lisinopril | Lisinopril | 387 | 60 |
| Mirtazapine | Mirtazapine | 349 | 52 |
| Metformin Hcl | Metformin Hcl | 306 | 54 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 295 | 37 |
| Sertraline Hcl | Sertraline Hcl | 294 | 51 |
| Clonazepam | Clonazepam | 283 | 31 |
| Donepezil Hcl | Donepezil Hcl | 283 | 43 |
| Divalproex Sodium | Divalproex Sodium | 269 | 34 |
| Baclofen | Baclofen | 250 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 238 | 28 |
| Omeprazole | Omeprazole | 236 | 53 |
| Montelukast Sodium | Montelukast Sodium | 234 | 49 |
| Metoprolol Tartrate | Metoprolol Tartrate | 233 | 39 |
| Meloxicam | Meloxicam | 227 | 60 |
| Alprazolam | Alprazolam | 218 | 23 |
| Buspirone Hcl | Buspirone Hcl | 210 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 210 | 37 |
| Trazodone Hcl | Trazodone Hcl | 207 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 205 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 194 | 58 |
| Quetiapine Fumarate | Quetiapine Fumarate | 192 | 36 |
| Fentanyl | Fentanyl | 191 | 17 |
| Lorazepam | Lorazepam | 190 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 185 | 35 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 181 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 177 | 32 |
| Levetiracetam | Levetiracetam | 164 | 26 |
| Tramadol Hcl | Tramadol Hcl | 157 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 152 | 17 |
| Spironolactone | Spironolactone | 150 | 25 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 147 | 38 |
| Oxycodone Hcl | Oxycodone Hcl | 145 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 140 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 138 | 26 |
| Glimepiride | Glimepiride | 138 | 32 |
| Simvastatin | Simvastatin | 135 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 133 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 131 | 28 |
| Famotidine | Famotidine | 131 | 28 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 129 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 129 | 13 |
| Metoprolol Succinate | Metoprolol Succinate | 126 | 30 |
| Ondansetron Hcl | Ondansetron Hcl | 126 | 51 |
| Risperidone | Risperidone | 104 | 14 |
| Xarelto | Rivaroxaban | 104 | suppressed |
| Olanzapine | Olanzapine | 101 | 14 |
| Pregabalin | Pregabalin | 101 | 14 |
| Sucralfate | Sucralfate | 101 | 18 |
| Allopurinol | Allopurinol | 97 | 13 |
| Atenolol | Atenolol | 95 | 16 |
| Ezetimibe | Ezetimibe | 95 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 95 | 37 |
| Azithromycin | Azithromycin | 94 | 68 |
| Jardiance | Empagliflozin | 93 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 92 | 22 |
| Memantine Hcl | Memantine Hcl | 92 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 20 |
| Cefdinir | Cefdinir | 88 | 69 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 88 | 28 |
| Aripiprazole | Aripiprazole | 87 | 20 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 85 | suppressed |
| Myrbetriq | Mirabegron | 84 | suppressed |
| Levofloxacin | Levofloxacin | 83 | 62 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 82 | 12 |
| Januvia | Sitagliptin Phosphate | 78 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 76 | 13 |
| Latanoprost | Latanoprost | 73 | suppressed |
| Topiramate | Topiramate | 73 | 12 |
| Metoclopramide Hcl | Metoclopramide Hcl | 72 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 67 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 67 | 25 |
| Torsemide | Torsemide | 66 | 14 |
| Warfarin Sodium | Warfarin Sodium | 66 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 65 | 46 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 64 | 45 |
| Dapagliflozin | Dapagliflozin Propanediol | 64 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 60 | suppressed |
| Prednisone | Prednisone | 60 | 25 |
| Temazepam | Temazepam | 60 | suppressed |
| Ranolazine Er | Ranolazine | 59 | suppressed |
| Finasteride | Finasteride | 58 | 11 |
| Mounjaro | Tirzepatide | 58 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 58 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 56 | 18 |
| Methocarbamol | Methocarbamol | 55 | 12 |
| Diazepam | Diazepam | 54 | suppressed |
| Fluconazole | Fluconazole | 54 | 33 |
| Bupropion Xl | Bupropion Hcl | 52 | suppressed |
| Rivastigmine | Rivastigmine | 50 | suppressed |
| Digoxin | Digoxin | 49 | suppressed |
| Nystatin | Nystatin | 49 | 30 |
| Amiodarone Hcl | Amiodarone Hcl | 47 | 14 |
| Cilostazol | Cilostazol | 47 | suppressed |
| Glipizide | Glipizide | 47 | suppressed |
| Movantik | Naloxegol Oxalate | 46 | suppressed |
| Gemfibrozil | Gemfibrozil | 45 | suppressed |
| Humalog | Insulin Lispro | 45 | suppressed |
| Insulin Aspart | Insulin Aspart | 45 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 45 | suppressed |
| Cephalexin | Cephalexin | 42 | 20 |
| Methadone Hcl | Methadone Hcl | 42 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 42 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 42 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 42 | suppressed |
| Nifedipine Er | Nifedipine | 41 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 40 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 40 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 40 | 11 |
| Oxcarbazepine | Oxcarbazepine | 39 | suppressed |
| Lactulose | Lactulose | 38 | 13 |
| Lamotrigine | Lamotrigine | 38 | suppressed |
| Linzess | Linaclotide | 38 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 37 | suppressed |
| Lovastatin | Lovastatin | 37 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 37 | suppressed |
| Primidone | Primidone | 37 | suppressed |
| Insulin Lispro | Insulin Lispro | 36 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 36 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 35 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 34 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 33 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 32 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 32 | suppressed |
| Celecoxib | Celecoxib | 31 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 31 | suppressed |
| Tradjenta | Linagliptin | 31 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | 13 |
| Santyl | Collagenase Clostridium Hist. | 30 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 30 | suppressed |
| Amoxicillin | Amoxicillin | 29 | 16 |
| Hydrocortisone | Hydrocortisone | 29 | suppressed |
| Mirabegron Er | Mirabegron | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 17 |
| Novolog | Insulin Aspart | 29 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | 12 |
| Alogliptin | Alogliptin Benzoate | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 16 |
| Valproic Acid | Valproic Acid | 27 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Klor-Con M20 | Potassium Chloride | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 24 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 24 | 16 |
| Lagevrio (Eua) | Molnupiravir | 23 | 23 |
| Lyrica | Pregabalin | 23 | suppressed |
| Timolol Maleate | Timolol Maleate | 23 | suppressed |
| Budesonide | Budesonide | 22 | 11 |
| Dexamethasone | Dexamethasone | 22 | 22 |
| Zonisamide | Zonisamide | 22 | suppressed |
| Austedo Xr | Deutetrabenazine | 21 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 21 | 16 |
| Entresto | Sacubitril/Valsartan | 21 | suppressed |
| Levemir | Insulin Detemir | 21 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 21 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 20 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 20 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Enulose | Lactulose | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 19 | suppressed |
| Clonidine | Clonidine | 19 | suppressed |
| Dulera | Mometasone/Formoterol | 19 | suppressed |
| Metronidazole | Metronidazole | 19 | 15 |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | suppressed |
| Oxycontin | Oxycodone Hcl | 17 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 16 | 12 |
| Nateglinide | Nateglinide | 16 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 16 | suppressed |
| Nystop | Nystatin | 16 | 11 |
| Ozempic | Semaglutide | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 15 | suppressed |
| Ingrezza | Valbenazine Tosylate | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 13 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 13 | suppressed |
| Modafinil | Modafinil | 13 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Ofloxacin | Ofloxacin | 11 | suppressed |
| Ropinirole Er | Ropinirole Hcl | 11 | suppressed |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $52.64 · 2 records | Otsuka America Pharmaceutical, Inc. | REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error